MELANIE HANEY: Open Payments
NPI 1013324631 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 16 payments from 14 companies in 2025. Trend: 2023 $550 · 2024 $149 · 2025 $382
Food & beverage: $332Education: $50
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 1 | $121 |
| Gilead Sciences, Inc. | 1 | $50 |
| Janssen Biotech, Inc. | 2 | $36 |
| Iovance Biotherapeutics, Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Celgene Corporation | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| SOBI, INC | 1 | $14 |
Products named: BESREMI, Trodelvy, Amtagvi, DARZALEX, Enhertu, CARVYKTI, KEYTRUDA, OPDUALAG.
Industry payments across AR — which companies pay providers there.
